Straumann Holding AG Stock Deutsche Boerse AG

Equities

QS51

CH1175448666

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG 04:55:04 2019-06-28 EDT 5-day change 1st Jan Change
77.8 EUR +1.46% Intraday chart for Straumann Holding AG -.--% -.--%

Financials

Sales 2024 * 2.59B 2.84B 2.65B 3.88B Sales 2025 * 2.89B 3.17B 2.96B 4.33B Capitalization 22.13B 24.27B 22.66B 33.19B
Net income 2024 * 481M 527M 493M 721M Net income 2025 * 581M 637M 595M 871M EV / Sales 2024 * 8.45 x
Net cash position 2024 * 262M 287M 268M 393M Net cash position 2025 * 553M 607M 566M 829M EV / Sales 2025 * 7.47 x
P/E ratio 2024 *
46.2 x
P/E ratio 2025 *
38.3 x
Employees 10,832
Yield 2024 *
0.66%
Yield 2025 *
0.78%
Free-Float 67.25%
More Fundamentals * Assessed data
Dynamic Chart
5 years
71.04
Extreme 71.04
778.00
10 years
15.67
Extreme 15.6653
778.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 06-12-31
Director of Finance/CFO 45 23-08-20
Chief Operating Officer - 22-03-31
Members of the board TitleAgeSince
Director/Board Member 61 89-12-31
Director/Board Member 57 23-04-04
Director/Board Member 61 19-12-31
More insiders
Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
138.8 CHF
Average target price
141.7 CHF
Spread / Average Target
+2.07%
Consensus